Piperaquine manufacturers
- Piperaquine USP/EP/BP
-
- $1.10
-
2026-08-20
- CAS:83764-65-2
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons Min
- Piperaquine
-
-
2020-04-28
- CAS:83764-65-2
- Min. Order: 1KG
- Purity: 99.0%
- Supply Ability: 500 tons
|
| | Piperaquine Basic information |
| Product Name: | Piperaquine | | Synonyms: | Piperaquine;Brn 0905079;Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro- (9ci);Quinoline, 4,4'-(trimethylenedi-4,1-piperazinediyl)bis(7-chloro-;Piperaquine USP/EP/BP | | CAS: | 83764-65-2 | | MF: | C29H32Cl2N6 | | MW: | 535.51058 | | EINECS: | | | Product Categories: | | | Mol File: | 83764-65-2.mol |  |
| | Piperaquine Chemical Properties |
| InChIKey | UCRHFBCYFMIWHC-UHFFFAOYSA-N | | SMILES | N1=C2C(C=CC(Cl)=C2)=C(N2CCN(CCCN3CCN(C4=C5C(=NC=C4)C=C(Cl)C=C5)CC3)CC2)C=C1 |
| | Piperaquine Usage And Synthesis |
| Pharmaceutical Applications | A bisquinoline used to treat malaria in China since 1978. It
is structurally related to chloroquine, but active against chloroquine-
resistant P. falciparum. A combination with dihdyroartemisinin
has shown excellent tolerability and high cure
rates for multidrug-resistant falciparum malaria.
It is highly lipid-soluble and orally well absorbed. The elimination
half-life is 20–30 days and there is extensive metabolism.
Adverse effects are similar to chloroquine, but pruritus
is uncommon. |
| | Piperaquine Preparation Products And Raw materials |
|